SCHEMBL7957460

SCHEMBL7957460

Fc1ccc(N2CCN(CCCc3cnc4n3CCCC4)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.48
DRD2 P14416 6/20 0.48
HTR2A P28223 6/20 0.48
DRD3 P35462 6/20 0.48
SIGMAR1 Q99720 5/20 0.48
TMEM97 Q5BJF2 4/20 0.48
DRD1 P21728 3/20 0.48
DRD5 P21918 3/20 0.48
HRH1 P35367 4/20 0.47
HTR2C P28335 1/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
THRB P10828 1/20 0.46
SLC27A1 Q6PCB7 1/20 0.44
DRD4 P21917 1/20 0.43
SLC6A4 P31645 1/20 0.43
RAB9A P51151 1/20 0.43
UBE2N P61088 1/20 0.43
HRH2 P25021 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7949256 0.99 THRB (0.47) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7949455 0.89 MAPK1 (0.46) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7963618 0.89 SIGMAR1 (0.51) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7957292 0.88 SIGMAR1 (0.52) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7949350 0.88 SIGMAR1 (0.50) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7967634 0.80 HTR1A (0.51) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7957534 0.73 DRD3 (0.58) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL8011318 0.72 DRD2 (0.69) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7963783 0.71 DRD2 (0.48) HTR1ADRD2HTR2ADRD3SIGMAR1
SCHEMBL7960226 0.70 DRD2 (0.47) HTR1ADRD2HTR2ADRD3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP claimed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed